We developed I3MV- 8b, an I3MO derivative, integrating an HDAC6 inhibitor moiety to enhance dual inhibition of proteasome and autophagy pathways.<h4>Methods</h4>The anti-MM effects of I3MV- 8b were tested in vitro and in vivo. The gene discussed is HDAC6; the disease is Miyoshi myopathy.